Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Geography

 

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

Swine Vaccines Market size is expected to be valued at USD 1,632.1 million in 2021 and is expected to grow at a CAGR of 5.1% during the forecast period 2022 to 2028. The global market provides a detailed overview of the swine vaccines market and which can be segmented by vaccine type, disease type, distribution channel, and region. By vaccine type, the swine vaccines market has been segmented into inactivated vaccines, recombinant vaccines, live attenuated vaccines, DNA vaccines, subunit vaccines, and others. By vaccine type, the inactivated vaccines segment dominated the market and registered for having a significant revenue share of XX% during 2022-2028 owing to its easy availability, reasonable cost, and stability advantages over live-attenuated vaccines.  Also, it minimizes the risk of virulence reversion after vaccination, as it prevents the replication process of pathogens. Furthermore, it offers swine better immunization with a rapid cell-mediated immune response. Immunity obtained from inactivated vaccines can be further improved with adjuvants such as certain types of oils or aluminum hydroxide. By disease type, the swine vaccine market has been segmented into viral infections, bacterial infections, parasitic infections, fungal infections, and others. By disease type, the viral infections segment held the largest revenue share of the swine vaccines market in the past few years and is projected to have a rapid growth rate over the forecasted period due to continuous increasing viral infections among a large part of the population due to various swine diseases. Based on the distribution channel, the segment has been segregated into veterinary hospitals, veterinary pharmacies, and online pharmacies. The online pharmacies segment is expected to lead the distribution channel segments during the forecasted period with a significant market share.

Key Development:

In May 2022, TwistPak®: Mixing platform for swine vaccines brings convenience and flexibility. In March 2022, Boehringer Ingelheim launched the swine industry’s first pcv2d-based vaccine.

Swine Vaccines Market Summary

Study Period

2023-29

Base Year

2022

CAGR

5.1%

Largest Market

Asia-Pacific

Fastest Growing Market

Europe
Swine Vaccines Market Dynamics

Rising swine disease outbreaks primarily drive the market. Also, some highly contagious swine diseases such as porcine reproductive and respiratory syndrome (PRRS) and swine influenza remain to be increasing in prevalence among swine herds in Asia, Europe, and American regions contributing to severe economic loss. Thus, to curb the effect swine producers are widely implementing biosecurity measures and vaccination processes. These factors will expect to expand the swine vaccines market globally in the upcoming few years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Swine Vaccines Market Segmentation

By Vaccine Type
  • Inactivated Vaccines
  • Recombinant vaccines
  • Live attenuated vaccines
  • DNA vaccines
  • Subunit vaccines
  • Others
By Disease Type
  • Viral Infections
  • Bacterial Infections
  • Parasitic Infection
  • Fungal Infections
  • Others
Distribution Channel
  • Veterinary Hospitals
  • Veterinary Pharmacies
  • Online Pharmacies

Frequently Asked Questions

Based on the vaccine type, the inactivated vaccines segment dominated and accounted for the largest revenue share of about 31.0% in 2021 attributable due to easy accessibility, low cost, nominal risk of revert reaction of killed viruses, and continuous new improvements by prominent players.      

The major factors driving the market growth are the increasing prevalence of diseases in swine, the upsurges in the demand for animal protein, and the advancement in vaccination services.

Increasing awareness about the importance of animal health and the rising demand for meat & poultry products are expected to drive market growth.

Table of Content
  1. Executive Summary
  2. Global Swine Vaccines Market Introduction
    • Global Swine Vaccines Market – Taxonomy
    • Global Swine Vaccines Market –Definitions
      • Product Type
      • Disease Type
      • Route of Administration
      • Region
  1. Global Swine Vaccines Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Swine Vaccines Market Dynamic Factors - Impact Analysis
    • Launch of Novel Vaccines
    • Product Landscape
  2. Global Swine Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Swine Vaccines Market, By Product Type, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Inactivated Vaccines
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Attenuated Live Vaccines
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Autogenous Vaccines
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Swine Vaccines Market, By Disease Type, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Aujeszky's Disease
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Foot and Mouth Disease
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • PRRS
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Actinobacillus Pleuropneumoniae
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Swine Vaccines Market, By Route of Administration, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Oral
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Injection
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Swine Vaccines Market Forecast, By Region, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Swine Vaccines Market - Opportunity Analysis Index, By Product Type, By Disease Type, By Route of Administration, and Region, 2020 - 2026
  2. North America Swine Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Attenuated Live Vaccines
      • Inactivated Vaccines
      • Autogenous Vaccines
      • Others
    • Disease Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Aujeszky's Disease
      • Foot and Mouth Disease
      • PRRS
      • Actinobacillus pleuropneumoniae
      • Others
    • Route of Administration Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Oral
      • Injection
    • Country Analysis 2016 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Swine Vaccines Market - Opportunity Analysis Index, By Product Type, Disease Type, Route of Administration, and Country, 2020 - 2026
    • North America Swine Vaccines Market Dynamics – Trends
  3. Europe Swine Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Attenuated Live Vaccines
      • Inactivated Vaccines
      • Autogenous Vaccines
      • Others
    • Disease Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Aujeszky's Disease
      • Foot and Mouth Disease
      • PRRS
      • Actinobacillus pleuropneumoniae
      • Others
    • Route of Administration Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Oral
      • Injection
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Swine Vaccines Market - Opportunity Analysis Index, By Product Type, Disease Type, Route of Administration, and Country, 2020 - 2026
    • Europe Swine Vaccines Market Dynamics – Trends
  4. Asia-Pacific Swine Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Attenuated Live Vaccines
      • Inactivated Vaccines
      • Autogenous Vaccines
      • Others
    • Disease Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Aujeszky's Disease
      • Foot and Mouth Disease
      • PRRS
      • Actinobacillus pleuropneumoniae
      • Others
    • Route of Administration Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Oral
      • Injection
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Swine Vaccines Market - Opportunity Analysis Index, By Product Type, Disease Type, Route of Administration, and Country, 2020 - 2026
    • Asia-Pacific Swine Vaccines Market Dynamics – Trends
  5. Latin America Swine Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Attenuated Live Vaccines
      • Inactivated Vaccines
      • Autogenous Vaccines
      • Others
    • Disease Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Aujeszky's Disease
      • Foot and Mouth Disease
      • PRRS
      • Actinobacillus pleuropneumoniae
      • Others
    • Route of Administration Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Oral
      • Injection
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Swine Vaccines Market - Opportunity Analysis Index, By Product Type, Disease Type, Route of Administration, and Country, 2020 - 2026
    • Latin America Swine Vaccines Market Dynamics – Trends
  6. Middle East and Africa Swine Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn)
    • Product Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Attenuated Live Vaccines
      • Inactivated Vaccines
      • Autogenous Vaccines
      • Others
    • Disease Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Aujeszky's Disease
      • Foot and Mouth Disease
      • PRRS
      • Actinobacillus pleuropneumoniae
      • Others
    • Route of Administration Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Oral
      • Injection
    • Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Swine Vaccines Market - Opportunity Analysis Index, By Product Type, Disease Type, Route of Administration, and Country, 2020 - 2026
    • MEA Swine Vaccines Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Ceva
      • Boehringer Ingelheim
      • Merck Animal Health
      • Zoetis
      • Phibro
  1. Research Methodology
  2. Key Assumptions and Acronyms
Disclaimer The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.
  • Zoetis (Pfizer, Inc.) (U.S.)
  • Merck & Co. Inc. (U.S)
  • Virbac S.A. (France)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Elanco (U.S.)
  • Bayer Animal Health (Germany)
  • Ceva Sante Animale (France)
  • Wilbur-Ellis Feed, LLC (U.S.)
  • Vetoquinol S.A. (France)